A Phase Ib Study of Nivolumab in Patients With Autoimmune Disorders and Advanced Malignancies (AIM-NIVO)
Sponsor:National Cancer Institute (NCI)Brief Summary: This phase Ib trial studies the side effects of nivolumab and to see how well…
Sponsor:National Cancer Institute (NCI)Brief Summary: This phase Ib trial studies the side effects of nivolumab and to see how well…
Sponsor:Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyBrief Summary: The study is to evaluate the efficacy…
Sponsor:BiogenBrief Summary: The primary objective is to evaluate the feasibility of the Multiple Sclerosis Performance Test (MSPT) in a clinical…
Sponsor:Novartis PharmaceuticalsBrief Summary: The open label study to evaluate effectiveness of treatment with ofatumumab in patients transitioning from commonly used…
Sponsor:Immune Response BioPharma, Inc.Brief Summary: A Phase I Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple…
Sponsor:EMD Serono Research & Development Institute, Inc.Brief Summary: To evaluate the effectiveness and safety of cladribine tablets in participants with…
Sponsor:Genentech, Inc.Brief Summary: This is an open-label, multicenter study that includes a main study for all participants enrolled and an…
Sponsor:University of California, San FranciscoBrief Summary: The overall goal of this project is to identify, assess and longitudinally monitor subjects…
Sponsor:EMD Serono Research & Development Institute, Inc.Brief Summary: To evaluate the effectiveness and safety of cladribine tablets in participants with…
Sponsor:University of California, San FranciscoBrief Summary: The goal of the current project is to measure the levels of ocrelizumab in…